Odisha government is preparing to establish a pharmaceutical manufacturing hub, which has the potential to significantly impact job creation and economic development in the state. In preparation for the major investment summit Utkarsh Odisha: Make...
Hikma Pharmaceuticals PLC, the global pharmaceutical company, has formed an exclusive commercial alliance with Emergent BioSolutions for marketing KLOXXADO naloxone HCl nasal spray 8 mg in the U.S. and Canada. KLOXXADO received approval from the...
Roche announced that it has obtained 510(k) approval from the United States Food and Drug Administration (FDA) for its ultra-sensitive in-situ hybridisation (ISH) assay, the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail. The assessment...
ProMIS Neurosciences Inc., a biotechnology company at the clinical stage aimed at creating precise therapies for neurodegenerative diseases, announced the start of its phase 1b clinical trial (PRECISE-AD) assessing its primary therapeutic...
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical firm, announced encouraging topline findings from an open-label, phase 2 study on congenital adrenal hyperplasia (CAH) using investigational atumelnant, a new, once-daily oral...
Cycle Pharmaceuticals, Inc. (Cycle) has announced the successful acquisition of Banner Life Sciences, LLC (Banner), which encompasses its BAFIERTAM® (monomethyl fumarate) product for treating relapsing forms of multiple sclerosis (MS) in adults...
Iconovo AB, a company specializing in inhalable medications created with unique inhalers and dry powder formulations, has partnered with Lonza, a healthcare development and manufacturing firm, to develop spray-dried formulations of an intranasal...
AI technology is set to greatly reduce research and development expenses in pharmaceuticals by streamlining drug discovery, enhancing clinical trials, and utilizing predictive data analytics, as per GlobalData survey. The leading data and...
Newron Pharmaceuticals S.p.A, a biopharmaceutical firm dedicated to creating innovative treatments for disorders of the central and peripheral nervous systems, along with Myung In Pharm Co. Ltd. (Myung In Pharm), the foremost CNS-focused...
CAGE Bio, Inc., a biotechnology firm in clinical development focusing on novel treatments for prevalent immuno-dermatological conditions, announced the start of a phase 2b dose-ranging study for its CGB-500 product. This topical JAK inhibitor...
, CDSCO.jpg)
